10th Jun 2020 11:00 am |
RNS |
Issue of Equity |
5th Jun 2020 4:19 pm |
RNS |
Director/PDMR Shareholding |
26th May 2020 2:39 pm |
RNS |
Update on 2019 AGM resolution vote |
1st May 2020 8:00 am |
RNS |
Appointment of Nominated Adviser and Joint Broker |
16th Apr 2020 7:00 am |
RNS |
Exclusive licensing agreement and trading update |
24th Mar 2020 7:00 am |
RNS |
Purchase of shares and PDMR notification |
11th Mar 2020 9:11 am |
RNS |
Holding(s) in Company |
6th Mar 2020 7:54 am |
RNS |
Holding(s) in Company |
28th Feb 2020 2:55 pm |
RNS |
Holding(s) in Company |
25th Feb 2020 7:00 am |
RNS |
Half Year Results |
4th Feb 2020 9:00 am |
RNS |
Notification of half year results |
16th Jan 2020 7:00 am |
RNS |
Half Year Trading Update |
14th Jan 2020 7:00 am |
RNS |
Agreement with Iovance to supply Proleukin® |
4th Dec 2019 9:28 am |
RNS |
Grant of share options and PDMR notification |
26th Nov 2019 10:53 am |
RNS |
Result of AGM |
31st Oct 2019 9:46 am |
RNS |
Total Voting Rights |
29th Oct 2019 11:18 am |
RNS |
Grant of share options and PDMR notification |
16th Oct 2019 10:12 am |
RNS |
Issue of Equity |
3rd Oct 2019 7:00 am |
RNS |
Annual Report and Accounts and notice of AGM |
19th Sep 2019 12:37 pm |
RNS |
Director/PDMR Shareholding |
19th Sep 2019 7:00 am |
RNS |
International platform taking shape |
5th Aug 2019 11:00 am |
RNS |
Notification of full year results date |
16th Jul 2019 7:00 am |
RNS |
Year end trading update |
28th Jun 2019 11:00 am |
RNS |
Total Voting Rights |
26th Jun 2019 7:00 am |
RNS |
MHRA licenses two Melatonin products |
3rd Jun 2019 9:00 am |
RNS |
Issue of Equity |
28th May 2019 6:02 pm |
RNS |
Holding(s) in Company |
15th May 2019 7:00 am |
RNS |
US commercial rights of Ethyol® and Totect® |
2nd Apr 2019 7:00 am |
RNS |
Clinigen completes US Proleukin rights acquisition |
29th Mar 2019 2:40 pm |
RNS |
Grant of share options and PDMR notification |
27th Feb 2019 7:00 am |
RNS |
Half Year Results |
25th Feb 2019 3:45 pm |
RNS |
Holding(s) in Company |
13th Feb 2019 7:00 am |
RNS |
Clinigen to acquire US rights to Proleukin® |
12th Feb 2019 7:00 am |
RNS |
Notification of half year results date |
5th Feb 2019 10:00 am |
RNS |
Appointment of CFO |
15th Jan 2019 7:00 am |
RNS |
Half Year trading update |
30th Nov 2018 2:55 pm |
RNS |
Issue of Equity |
28th Nov 2018 7:00 am |
RNS |
Capital Markets Day |
15th Nov 2018 9:00 am |
RNS |
Board Appointment |
8th Nov 2018 3:39 pm |
RNS |
Result of AGM |